Breaking Research · Johns Hopkins & University of Tokyo
The “Vicks VapoRub Prostate” Method: How a Pittsburgh Urologist Used Menthol Science to Develop a New Enlarged Prostate Treatment
For decades, doctors told men that an enlarged prostate was simply part of aging. Now, Johns Hopkins microbiota research suggests the real culprit may be invisible — and a urologist claims he’s found how to reduce enlarged prostate inflammation using compounds found in an unexpected household product.
A Pittsburgh urologist reveals how to reduce enlarged prostate inflammation using menthol-based compounds. Watch the full presentation.
Watch the Full Presentation →Free access · Limited availability
Research illustration: nanotoxins identified in water, air and food are believed to disrupt the prostate microbiota — creating conditions for bacterial overgrowth and chronic inflammation.
Benign prostatic hyperplasia — more commonly known as an enlarged prostate — affects more than 40% of men over 50 and nearly 90% of men over 70. For most of these men, the experience is the same: waking up multiple times a night, a weak or interrupted urinary stream, and the embarrassing urgency that never fully resolves — even after trying every conventional enlarged prostate treatment their doctor prescribed.
What has puzzled researchers for years is why the most common enlarged prostate treatments — alpha-blockers, 5-alpha-reductase inhibitors, and minimally invasive procedures — tend to provide temporary relief but rarely address the underlying progression. For many men, the condition worsens over time despite consistent treatment.
Clinical Symptom Assessment
Do Your Symptoms Match the Profile Identified in the Research?
Answer 5 quick questions to understand where you stand — based on symptom patterns from the Johns Hopkins microbiota studies.
Question 1 of 5
How many times do you typically wake up at night to urinate?
How would you describe your urinary stream strength?
After urinating, how often do you feel the bladder wasn’t fully emptied?
Does urgency affect your daily activities — work, travel, social situations?
How long have you been experiencing these urinary symptoms?
This assessment is for informational purposes only and is not a medical diagnosis. Always consult your physician.
A New Line of Investigation: The Prostate Microbiome
Recent studies out of Johns Hopkins University and the University of Tokyo have begun mapping what researchers are calling the “prostate microbiota” — a distinct community of microorganisms that appears to play a significant role in prostate inflammation and tissue behavior.
The central hypothesis is that an imbalance in the prostate microbiota — not simply age-related hormone changes — may be the primary driver of the chronic inflammation associated with benign prostatic hyperplasia. When the protective microbial balance is disrupted, the tissue surrounding the urethra becomes inflamed and begins to exert pressure on urinary flow.
“What was discovered completely debunks the belief that an enlarged prostate is simply due to aging or genetic factors.”
— Dr. Claus Rohrerborn, Chair, Department of Urology, UT Southwestern Medical CenterInvestigators have identified a class of nanotoxins — microscopic particles found in water sources, air, and processed foods — as a potential trigger for disrupting the prostate’s microbial environment. These particles may create conditions that allow certain bacterial strains to proliferate unchecked, promoting chronic low-grade inflammation in the surrounding tissue.
Why Conventional Medicine Hasn’t Addressed This
The global market for prostate medications exceeds $4 billion annually. Treatments that manage symptoms — rather than resolve root causes — sustain that market. Research that challenges the dominant treatment paradigm faces significant headwinds in finding institutional support.
Standard medications that relax smooth muscle tissue may provide temporary symptomatic relief, but according to the microbiota research, they do not address the underlying bacterial imbalance or the inflammation it produces. This may explain why symptoms often return — and escalate — over time.
The “Vicks VapoRub Prostate” Discovery — Why Menthol Matters
One of the most unexpected threads to emerge from the microbiota research involves menthol — the same compound found in Vicks VapoRub. A Pittsburgh-based urologist, Dr. Ethan Caldwell, noticed that menthol activates specific cold-sensitive receptors (TRPM8) found in prostate tissue. In laboratory settings, this activation appeared to reduce inflammatory markers and inhibit the growth of aggressive bacterial strains.
The term “Vicks VapoRub prostate” began trending in health communities after men who watched Dr. Caldwell’s presentation started searching for more information about the menthol connection. The method does not involve applying Vicks topically — rather, it uses pharmaceutical-grade menthol combined with two other botanical compounds (pumpkin seed extract and grape seed extract) in what Dr. Caldwell calls the “Functional Triad.”
The Three-Compound Approach
According to the research, pumpkin seed oil disrupts the biofilm that protects harmful bacteria, grape seed extract targets the bacteria directly with its proanthocyanidin compounds, and menthol dramatically increases the bioavailability of both — allowing them to reach the prostate tissue at effective concentrations. This combination approach is what differentiates the method from single-ingredient supplements like saw palmetto.
How to Reduce Enlarged Prostate Inflammation: What the Research Actually Suggests
For men researching how to reduce enlarged prostate size naturally, the standard advice — limit fluids before bed, cut caffeine, do Kegel exercises — provides modest symptom management at best. These approaches do not address the bacterial imbalance or chronic inflammation that the microbiota research points to as the underlying driver.
The more substantive intervention being discussed involves a multi-pronged approach: compounds that can reach the prostate at meaningful concentrations (the bioavailability problem that has plagued natural remedies for decades), substances with documented anti-inflammatory activity in prostate tissue, and elements that may help restore a healthier microbial balance — all delivered simultaneously.
The Urologist Who Broke Ranks
Dr. Ethan Caldwell, a urologist trained at Imperial College London now based in Pittsburgh, spent years reviewing the microbiota data. His motivation was deeply personal: he watched his own father suffer public humiliation at a Pittsburgh Steelers game when a urinary episode was caught on the stadium’s jumbotron screen in front of 60,000 fans.
“That moment destroyed him,” Dr. Caldwell explains in his presentation. “He was the strongest man I knew, and overnight he became someone who was afraid to leave the house.” That experience drove Caldwell to investigate why conventional enlarged prostate treatments had failed his father — and what he found led him to develop the method he now shares publicly.
Featured Presentation
Dr. Caldwell Reveals the “Vicks VapoRub Prostate” Method — and How to Reduce Enlarged Prostate Inflammation Naturally
He explains the bacterial cause, the three specific compounds involved, why conventional treatments fail — and the personal story that drove him to break from mainstream urology.
Watch the Full PresentationFree to watch · No registration required · Limited availability
What to Watch For
The question of how to reduce enlarged prostate symptoms may have a more specific answer than most men have been given. Whether the Vicks VapoRub prostate connection holds up under further scrutiny remains to be seen — but Dr. Caldwell’s presentation is currently the most complete public account of the research and the method he developed from it.